Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session IX: Hepatocellular Cancer
SO-13: Pembrolizumab in patients with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: updated data from the open-label, phase 2 KEYNOTE-224 study
Thursday, June 30, 2022
15:50 – 15:58
Location: Auditorium A; Level 0
Abstract Presenter(s)
Arndt Vogel, MD
Medizinische Hochschule Hannover
Hannover, Germany
